{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:14:36Z","timestamp":1791483276256,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-023-00615-z","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T04:01:55Z","timestamp":1702094515000},"page":"539-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of Allopurinol in Improving Endothelial Dysfunction: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4850-2125","authenticated-orcid":false,"given":"Shurjeel Uddin","family":"Qazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Talha","family":"Maqsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabbia","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad Ali","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeeshan","family":"Imtiaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amatul","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahammed Zia Khan","family":"Suheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaofashan","family":"Zaheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeela","family":"Andleeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masooma","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shariq","family":"Akram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarak","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Barmanwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutab","family":"Tareen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfa","family":"Zaheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,9]]},"reference":[{"issue":"3","key":"615_CR1","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, Ilyas I, Little PJ, Hong, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, Harding IC, Ebong EE, Cameron SJ, Stewart AG, Weng J. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73(3):924\u201367. https:\/\/doi.org\/10.1124\/pharmrev.120.000096.","journal-title":"Pharmacol Rev"},{"issue":"10","key":"615_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.res.87.10.840","volume":"87","author":"H Cai","year":"2000","unstructured":"Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87(10):840\u20134. https:\/\/doi.org\/10.1161\/01.res.87.10.840.","journal-title":"Circ Res"},{"issue":"6","key":"615_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1096\/fasebj.1.6.3315807","volume":"1","author":"LJ Machlin","year":"1987","unstructured":"Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J. 1987;1(6):441\u20135. https:\/\/doi.org\/10.1096\/fasebj.1.6.3315807.","journal-title":"FASEB J"},{"key":"615_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0757-9","author":"M Bredemeier","year":"2018","unstructured":"Bredemeier M, Lopes LM, Eisenreich MA, Hickmann S, Bongiorno G, Davila R, Morsch A, Da Silva Stein F, Campos GGD. Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2018. https:\/\/doi.org\/10.1186\/s12872-018-0757-9.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"615_CR5","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/01.hyp.35.3.746","volume":"35","author":"RJ Butler","year":"2018","unstructured":"Butler RJ, Morris AD, Belch JJF, Hill AJ, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2018;35(3):746\u201351. https:\/\/doi.org\/10.1161\/01.hyp.35.3.746.","journal-title":"Hypertension"},{"key":"615_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40292-014-0051-6","volume":"21","author":"D Grassi","year":"2014","unstructured":"Grassi D, Pontremoli R, Bocale R, Ferri C, Desideri G. Therapeutic approaches to chronic hyperuricemia and gout. High Blood Press Cardiovasc Prev. 2014;21:243\u201350. https:\/\/doi.org\/10.1007\/s40292-014-0051-6.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"6","key":"615_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2174\/1570161115666170919183657","volume":"16","author":"SR Britnell","year":"2018","unstructured":"Britnell SR, Chillari KA, Brown JN. The role of xanthine oxidase inhibitors in patients with history of stroke: a systematic review. Curr Vasc Pharmacol. 2018;16(6):583\u20138. https:\/\/doi.org\/10.2174\/1570161115666170919183657.","journal-title":"Curr Vasc Pharmacol"},{"issue":"11","key":"615_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41415-022-4359-7","volume":"232","author":"K Dickson","year":"2020","unstructured":"Dickson K, Yeung CA. PRISMA 2020 updated guideline. Br Dent J. 2020;232(11):760\u20131. https:\/\/doi.org\/10.1038\/s41415-022-4359-7.","journal-title":"Br Dent J"},{"issue":"4","key":"615_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/leap.1463","volume":"35","author":"SJ Chapman","year":"2022","unstructured":"Chapman SJ, Dossa F, De Groof EJ, Keane C, Van Ramshorst GH, Smart NJ. The AMSTAR -2 critical appraisal tool and editorial decision-making for systematic reviews: retrospective, bibliometric study. Learned Publishing. 2022;35(4):529\u201338. https:\/\/doi.org\/10.1002\/leap.1463.","journal-title":"Learned Publishing"},{"issue":"oct18 2","key":"615_CR10","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovi\u0107 J, Schulz KF, Weeks L, Sterne JAC. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(oct18 2):d5928. https:\/\/doi.org\/10.1136\/bmj.d5928.","journal-title":"BMJ"},{"issue":"7414","key":"615_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"issue":"4","key":"615_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.healun.2010.10.003","volume":"30","author":"D Greig","year":"2011","unstructured":"Greig D, Alca\u00edno H, Castro P, Garcia L, Verdejo H, Navarro M, L\u00f3pez RM, Mellado R, Tapia FM, Gabrielli L, Nogerol C, Chiong M, Godoy I, Lavandero S. Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters. J Heart Lung Transplant. 2011;30(4):408\u201313. https:\/\/doi.org\/10.1016\/j.healun.2010.10.003.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"615_CR13","first-page":"756","volume":"20","author":"J Xiao","year":"2016","unstructured":"Xiao J, Sb D, Q S, Li J, Gy K, Js W, Ma Y. Allopurinol ameliorates cardiac function in non-hyperuricaemic patients with chronic heart failure. PubMed. 2016;20(4):756\u201361.","journal-title":"PubMed"},{"issue":"1","key":"615_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.atherosclerosis.2010.11.002","volume":"214","author":"D Tousoulis","year":"2011","unstructured":"Tousoulis D, Andreou I, Tsiatas M, Miliou A, Tentolouris C, Siasos G, Papageorgiou NS, Papadimitriou C, Dimopoulos MA, Stefanadis C. Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress. Atherosclerosis. 2011;214(1):151\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.11.002.","journal-title":"Atherosclerosis"},{"issue":"1","key":"615_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12311","volume":"36","author":"TK Lim","year":"2017","unstructured":"Lim TK, Noman A, Choy AM, Khan F, Struthers AD, Lang CC. The APEX trial: effects of allopurinol on exercise capacity, coronary and peripheral endothelial function, and natriuretic peptides in patients with cardiac syndrome X. Cardiovasc Ther. 2017;36(1): e12311. https:\/\/doi.org\/10.1111\/1755-5922.12311.","journal-title":"Cardiovasc Ther"},{"issue":"9","key":"615_CR16","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jacc.2012.09.066","volume":"61","author":"S Rekhraj","year":"2013","unstructured":"Rekhraj S, Gandy SJ, Szwejkowski BR, Nadir MA, Noman A, Houston JG, Lang CC, George J, Struthers AD. High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease. J Am Coll Cardiol. 2013;61(9):926\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2012.09.066.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"615_CR17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jacc.2010.12.052","volume":"58","author":"NS Rajendra","year":"2011","unstructured":"Rajendra NS, Ireland S, George J, Belch JJF, Lang CC, Struthers AD. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. J Am Coll Cardiol. 2011;58(8):820\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2010.12.052.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"615_CR18","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.jacc.2013.07.074","volume":"62","author":"BR Szwejkowski","year":"2013","unstructured":"Szwejkowski BR, Gandy SJ, Rekhraj S, Houston JG, Lang CC, Morris AD, George J, Struthers AD. Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy. J Am Coll Cardiol. 2013;62(24):2284\u201393. https:\/\/doi.org\/10.1016\/j.jacc.2013.07.074.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"615_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/08037051.2010.538977","volume":"20","author":"A Dogan","year":"2010","unstructured":"Dogan A, Yarlioglues M, Kaya M, Karada\u011f Z, Do\u011fan S, Ardic I, Dogdu O, Kilinc Y, Zencir C, Akpek M, Ozdogru I, Oguzhan A, Kalay N. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients. Blood Press. 2010;20(3):182\u20137. https:\/\/doi.org\/10.3109\/08037051.2010.538977.","journal-title":"Blood Press"},{"issue":"5","key":"615_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00392-007-0636-3","volume":"97","author":"O Yiginer","year":"2007","unstructured":"Yiginer O, \u00d6z\u00e7elik F, Inanc T, Aparci M, \u00d6zmen N, Cing\u00f6zbay BY, Kardesoglu E, S\u00fcleymano\u011flu S, \u015eener G, Cebeci BS. Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome. Clin Res Cardiol. 2007;97(5):334\u201340. https:\/\/doi.org\/10.1007\/s00392-007-0636-3.","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"615_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ekir.2020.10.025","volume":"6","author":"E Rutherford","year":"2021","unstructured":"Rutherford E, Ireland S, Mangion K, Stewart G, MacGregor MS, Roditi G, Woodward R, Gandy SJ, Houston JG, Jardine AG, Rauchhaus P, Witham MD, Mark PB, Struthers AD. A randomized, controlled trial of the effect of allopurinol on left ventricular mass index in hemodialysis patients. Kidney Int Reports. 2021;6(1):146\u201355. https:\/\/doi.org\/10.1016\/j.ekir.2020.10.025.","journal-title":"Kidney Int Reports"},{"issue":"7","key":"615_CR22","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1681\/asn.2010111185","volume":"22","author":"M Kao","year":"2011","unstructured":"Kao M, Ang DSC, Gandy SJ, Nadir MA, Houston JG, Lang CC, Struthers AD. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol. 2011;22(7):1382\u20139. https:\/\/doi.org\/10.1681\/asn.2010111185.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"615_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10157-014-1012-z","volume":"19","author":"D Bayram","year":"2014","unstructured":"Bayram D, Sezer MT, Inal S, Altunta\u015f A, Kidir V, Orhan H. The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients. Clin Exp Nephrol. 2014;19(3):443\u20139. https:\/\/doi.org\/10.1007\/s10157-014-1012-z.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"615_CR24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1681\/asn.2016050521","volume":"28","author":"D Jalal","year":"2016","unstructured":"Jalal D, Decker E, Perrenoud L, Nowak KL, Bispham NZ, Mehta T, Smits G, You Z, Seals DR, Chonchol M, Johnson RJ. Vascular function and uric acid-lowering in stage 3 CKD. J Am Soc Nephrol. 2016;28(3):943\u201352. https:\/\/doi.org\/10.1681\/asn.2016050521.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"615_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/hypertensionaha.116.08488","volume":"69","author":"L Borgi","year":"2017","unstructured":"Borgi L, McMullan CJ, Wohlhueter AL, Curhan GC, Fisher ND, Forman JP. Effect of uric acid-lowering agents on endothelial function: a randomized, double-blind, placebo-controlled trial. Hypertension. 2017;69(2):243\u20138. https:\/\/doi.org\/10.1161\/hypertensionaha.116.08488.","journal-title":"Hypertension"},{"issue":"8","key":"615_CR26","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2215\/cjn.11451210","volume":"6","author":"M Kanbay","year":"2011","unstructured":"Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, Duranay M, Covic A, Johnson RJ. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011;6(8):1887\u201394. https:\/\/doi.org\/10.2215\/cjn.11451210.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"615_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cjca.2015.05.010","volume":"32","author":"AJ Robertson","year":"2016","unstructured":"Robertson AJ, Struthers AD. A randomized controlled trial of allopurinol in patients with peripheral arterial disease. Can J Cardiol. 2016;32(2):190\u20136. https:\/\/doi.org\/10.1016\/j.cjca.2015.05.010.","journal-title":"Can J Cardiol"},{"issue":"6","key":"615_CR28","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/ageing\/afaa061","volume":"49","author":"MD Witham","year":"2020","unstructured":"Witham MD, Clarke C, Hutcheon A, Gingles C, Gandy SJ, Priba L, Nicholas RS, Cavin I, Sumukadas D, Struthers AD, George J. Effect of allopurinol on phosphocreatine recovery and muscle function in older people with impaired physical function: a randomised controlled trial. Age And Ageing. 2020;49(6):1003\u201310. https:\/\/doi.org\/10.1093\/ageing\/afaa061.","journal-title":"Age And Ageing"},{"issue":"8","key":"615_CR29","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/art.41749","volume":"73","author":"AL Gaffo","year":"2021","unstructured":"Gaffo AL, Calhoun DA, Rahn EJ, Oparil S, Li P, Dudenbostel T, Feig DI, Redden DT, Muntner P, Foster PP, Biggers-Clark S, Mudano AS, Sattui SE, Saddekni MB, Bridges SL, Saag KG. Effect of serum urate lowering with allopurinol on blood pressure in young adults: a randomized, controlled, crossover trial. Arthritis Rheumatol. 2021;73(8):1514\u201322. https:\/\/doi.org\/10.1002\/art.41749.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"615_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1046\/j.1440-1681.1999.03125.x","volume":"26","author":"J O\u2019Driscoll","year":"1999","unstructured":"O\u2019Driscoll J, Green D, Rankin J, Taylor RR. Nitric oxide-dependent endothelial function is unaffected by allopurinol in hypercholesterolaemic subjects. Clin Exp Pharmacol Physiol. 1999;26(10):779\u201383. https:\/\/doi.org\/10.1046\/j.1440-1681.1999.03125.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"23","key":"615_CR31","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1161\/circulationaha.106.651117","volume":"114","author":"J George","year":"2006","unstructured":"George J, Carr E, Davies J, Belch JJF, Struthers AD. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114(23):2508\u201316. https:\/\/doi.org\/10.1161\/circulationaha.106.651117.","journal-title":"Circulation"},{"issue":"2","key":"615_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/01.cir.0000022140.61460.1d","volume":"106","author":"C Farquharson","year":"2002","unstructured":"Farquharson C, Butler RJ, Hill AJ, Belch JJF, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106(2):221\u20136. https:\/\/doi.org\/10.1161\/01.cir.0000022140.61460.1d.","journal-title":"Circulation"},{"key":"615_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","volume":"278","author":"T Maruhashi","year":"2018","unstructured":"Maruhashi T, Hisatome I, Kihara Y, Higashi Y. Hyperuricemia and endothelial function: from molecular background to clinical perspectives. Atherosclerosis. 2018;278:226\u201331. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.10.007.","journal-title":"Atherosclerosis"},{"issue":"6","key":"615_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/1755-5922.12215","volume":"34","author":"X Wei","year":"2016","unstructured":"Wei X, Mi S, Lin Z. Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials. Cardiovasc Ther. 2016;34(6):441\u20139. https:\/\/doi.org\/10.1111\/1755-5922.12215.","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"615_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40265-017-0839-5","volume":"78","author":"AFG Cicero","year":"2017","unstructured":"Cicero AFG, Pirro M, Watts GF, Mikhailidis DP, Banach M, Sahebkar A. Effects of allopurinol on endothelial function: a systematic review and meta-analysis of randomized placebo-controlled trials. Drugs. 2017;78(1):99\u2013109. https:\/\/doi.org\/10.1007\/s40265-017-0839-5.","journal-title":"Drugs"},{"issue":"4","key":"615_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000360609","volume":"39","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Siriopol D, Nistor I, Elcioglu OC, Telci O, Takir M, Johnson RJ, Covic A. Effects of allopurinol on endothelial dysfunction: a meta-analysis. Am J Nephrol. 2014;39(4):348\u201356. https:\/\/doi.org\/10.1159\/000360609.","journal-title":"Am J Nephrol"},{"issue":"4","key":"615_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12432","volume":"36","author":"MM Alem","year":"2018","unstructured":"Alem MM. Allopurinol and endothelial function: a systematic review with meta-analysis of randomized controlled trials. Cardiovasc Ther. 2018;36(4): e12432. https:\/\/doi.org\/10.1111\/1755-5922.12432.","journal-title":"Cardiovasc Ther"},{"issue":"10359","key":"615_CR38","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/s0140-6736(22)01657-9","volume":"400","author":"IS Mackenzie","year":"2022","unstructured":"Mackenzie IS, Hawkey CJ, Ford I, Greenlaw N, Pigazzani F, Rogers A, Struthers AD, Begg A, Wei L, Avery A, Taggar J, Walker A, Duce S, Barr R, Dumbleton J, Rooke ED, Townend JN, Ritchie LD, MacDonald TM, et al. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. The Lancet. 2022;400(10359):1195\u2013205. https:\/\/doi.org\/10.1016\/s0140-6736(22)01657-9.","journal-title":"The Lancet"},{"issue":"10","key":"615_CR39","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/j.1464-5491.2005.01630.x","volume":"22","author":"UR Kuppusamy","year":"2005","unstructured":"Kuppusamy UR, Indran M, Pendek R. Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian Type 2 diabetes patients. Diabetic Med. 2005;22(10):1343\u20136. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01630.x.","journal-title":"Diabetic Med"},{"key":"615_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4370490","author":"D Miric","year":"2016","unstructured":"Miric D, Kisic B, Filipovi\u0107-Dani\u0107 S, Grbi\u0107 R, Dragojevic I, Miric MB, Puhalo-Sladoje D. Xanthine oxidase activity in type 2 diabetes mellitus patients with and without diabetic peripheral neuropathy. J Diabetes Res. 2016. https:\/\/doi.org\/10.1155\/2016\/4370490.","journal-title":"J Diabetes Res"},{"issue":"15","key":"615_CR41","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/eurheartj\/ehi305","volume":"26","author":"V Mellin","year":"2005","unstructured":"Mellin V, Isabelle M, Oudot A, Vergely C, Monteil C, Di Meglio B, Henry JP, Dautreaux B, Rochette L, Thuillez C, Mulder P. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure. Eur Heart J. 2005;26(15):1544\u201350. https:\/\/doi.org\/10.1093\/eurheartj\/ehi305.","journal-title":"Eur Heart J"},{"issue":"8","key":"615_CR42","doi-asserted-by":"publisher","first-page":"12727","DOI":"10.3390\/molecules190812727","volume":"19","author":"B Choi","year":"2014","unstructured":"Choi B, Kang K, Kwak M. Effect of redox modulating NRF2 activators on chronic kidney disease. Molecules. 2014;19(8):12727\u201359. https:\/\/doi.org\/10.3390\/molecules190812727.","journal-title":"Molecules"},{"issue":"5","key":"615_CR43","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.amjcard.2003.11.046","volume":"93","author":"S Guthikonda","year":"2004","unstructured":"Guthikonda S, Woods KR, Sinkey CA, Haynes WG. Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers. Am J Cardiol. 2004;93(5):664\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2003.11.046.","journal-title":"Am J Cardiol"},{"key":"615_CR44","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-21925","author":"T Kamiya","year":"2017","unstructured":"Kamiya T, Nagaoka T, Omae T, Ono S, Otani S, Yoshida A. Benzo(e)pyrene Inhibits endothelium-dependent NO-mediated dilation of retinal arterioles via superoxide production and endoplasmic reticulum stress. Invest Ophthalmol Vis Sci. 2017. https:\/\/doi.org\/10.1167\/iovs.17-21925.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"615_CR45","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1080\/07853890701854702","volume":"40","author":"T M\u00fcnzel","year":"2008","unstructured":"M\u00fcnzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med. 2008;40(3):180\u201396. https:\/\/doi.org\/10.1080\/07853890701854702.","journal-title":"Ann Med"},{"issue":"9","key":"615_CR46","first-page":"1295","volume":"18","author":"G Desideri","year":"2014","unstructured":"Desideri G, Castaldo G, Lombardi A, Mussap M, Testa A, Pontremoli R, Punzi L, Borghi C. Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci. 2014;18(9):1295\u2013306.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"615_CR47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/ar3199","volume":"12","author":"E Roddy","year":"2010","unstructured":"Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010;12(6):223. https:\/\/doi.org\/10.1186\/ar3199.","journal-title":"Arthritis Res Ther"}],"updated-by":[{"DOI":"10.1007\/s40292-023-00619-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000}}],"container-title":["High Blood Pressure &amp; Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-023-00615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-023-00615-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-023-00615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T04:30:15Z","timestamp":1703219415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-023-00615-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,9]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["615"],"URL":"https:\/\/doi.org\/10.1007\/s40292-023-00615-z","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,9]]},"assertion":[{"value":"5 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40292-023-00619-9","URL":"https:\/\/doi.org\/10.1007\/s40292-023-00619-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The present meta-analysis does not involve direct data collection from human subjects or animals. All data used in this study were obtained from previously published and publicly available sources, adhering to the ethical guidelines of the respective studies. No identifiable patient information is presented in this meta-analysis<b>.<\/b>","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}}]}}